Inventor · disambiguated record
Masato Yoshikawa
Also filed as: YOSHIKAWA MASATO
39 granted patents·3 pending applications·124 citations·filing 2010–2024
97Inventor score
Files withTAKEDA PHARMACEUTICALS CO27TAKEDA PHARMACEUTICAL7TANIGUCHI TAKAHIKO6RAKER JOSEPH1YOSHIKAWA MASATO1
Top patents by PatentIndex Score
42 records- 0193US8648079B2Heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2012·Granted Feb 11, 2014·13 cites·3 claims
- 0291US9440990B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Sep 13, 2016·7 cites·8 claims
- 0391US8871766B2Heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Oct 28, 2014·8 cites·3 claims
- 0491US8865717B2Heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Oct 21, 2014·8 cites·3 claims
- 0590US11453661B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 27, 2022·2 cites·8 claims
- 0690US10980825B2Cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 20, 2021·6 cites·20 claims
- 0790US9193709B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICAL·Filed 2012·Granted Nov 24, 2015·8 cites·18 claims
- 0889US11666594B2Antibody-drug conjugates comprising a cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 6, 2023·2 cites·19 claims
- 0988US10787462B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 29, 2020·5 cites·14 claims
- 1087US11174272B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Nov 16, 2021·1 cites·16 claims
- 1187US10406146B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 10, 2019·4 cites·11 claims
- 1286US9586930B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Mar 7, 2017·3 cites·12 claims
- 1383US10357484B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 23, 2019·2 cites·13 claims
- 1483US10081624B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Sep 25, 2018·5 cites·14 claims
- 1583US9643957B2Heterocyclic compounds having cholesterol 24-hydroxylase activityTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted May 9, 2017·6 cites·12 claims
- 1682US8778944B2Pyridazinone compoundsTANIGUCHI TAKAHIKO·Filed 2012·Granted Jul 15, 2014·5 cites·38 claims
- 1782US2025205270A1Antibody-drug conjugate precursors comprising a cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1881US12384770B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2024·Granted Aug 12, 2025·0 cites·5 claims
- 1981US10550129B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Feb 4, 2020·1 cites·8 claims
- 2081US10273245B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 30, 2019·1 cites·11 claims
- 2181US8916566B2Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disordersTANIGUCHI TAKAHIKO·Filed 2010·Granted Dec 23, 2014·4 cites·37 claims
- 2280US12171777B2Methods of making a cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Dec 24, 2024·0 cites·20 claims
- 2379US10144743B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 4, 2018·1 cites·11 claims
- 2478US9598398B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Mar 21, 2017·4 cites·14 claims
- 2578US9150588B2Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitorsTANIGUCHI TAKAHIKO·Filed 2011·Granted Oct 6, 2015·5 cites·9 claims
- 2678US9090586B2Heterocyclic compoundYOSHIKAWA MASATO·Filed 2011·Granted Jul 28, 2015·5 cites·12 claims
- 2778US8563575B2Fused heterocyclic compoundsTANIGUCHI TAKAHIKO·Filed 2011·Granted Oct 22, 2013·4 cites·15 claims
- 2877US11958845B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Apr 16, 2024·0 cites·2 claims
- 2977US9550756B2Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disordersTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Jan 24, 2017·2 cites·37 claims
- 3075US9296746B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2013·Granted Mar 29, 2016·3 cites·13 claims
- 3175US8940758B2Fused heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jan 27, 2015·2 cites·17 claims
- 3275US8846713B2Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitorsTANIGUCHI TAKAHIKO·Filed 2011·Granted Sep 30, 2014·2 cites·2 claims
- 3374US10717748B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jul 21, 2020·0 cites·15 claims
- 3474US9226921B2Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitorsTAKEDA PHARMACEUTICAL·Filed 2014·Granted Jan 5, 2016·2 cites·17 claims
- 3572US10112956B2Heterocyclic compounds having cholesterol 24-hydroxylase activityTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 30, 2018·1 cites·11 claims
- 3667US9624184B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Apr 18, 2017·1 cites·10 claims
- 3765US9029388B2Condensed heterocyclic compoundTANIGUCHI TAKAHIKO·Filed 2012·Granted May 12, 2015·1 cites·13 claims
- 3858US2017114044A1Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disordersTAKEDA PHARMACEUTICALS CO·Filed 2016·Application pending·0 cites
- 3956US2023037538A1Anti-als compoundsTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 4049US12084436B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 10, 2024·0 cites·16 claims
- 4137US10308643B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 4, 2019·0 cites·12 claims
- 4231US9029536B2Fused heterocyclic compoundsRAKER JOSEPH·Filed 2011·Granted May 12, 2015·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Masato Yoshikawa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →